EB Repurposing Call 2023

The Joint Funding Call with our partner LifeArc culminated in the panel meeting in March 2024 in Vienna. In total, 9 EOI project proposals were triaged and invited to submit  full proposals, which then underwentan external peer-review process including due diligence provided by LifeArc. The Expert Panel comprised international experts with scientific and industry backgrounds. In addition, patient representatives were engaged in the whole process, including review.  According to the call’s remit, all projects were required to focus on preclinical to clinical research, within the drug repurposing space. Following evaluation, four projects of this joint funding call scored abovethe threshold for consideration for  funding. LifeArc and DEBRA Austria will now discuss various options to support the eligible projects in whole or in part with (smaller/larger) budgetary, content-related, and organizational adjustments. As soon as funding agreements are finalized, we will be able to publicize the funded projects.

More information on the call is provided on LifeArc’s and EB Resnet’s website.